The best of EcoWatch, right in your inbox. Sign up for our email newsletter!
CVS and Walgreens Stop Selling Zantac After Cancer-Causing Chemical Detected
By Julia Ries
Weeks after the popular heartburn drug ranitidine, known by the brand name Zantac, was found to contain a cancer-causing chemical, multiple drugstores have decided to no longer sell the medication.
CVS and Walgreens will no longer sell Zantac and other ranitidine medications, as the heartburn drugs might contain substances that could cause cancer.
Even though Zantac hasn't officially been recalled, CVS is currently offering customers who recently bought Zantac or another ranitidine drug a refund. The chain will continue to sell other over-the-counter heartburn medications, like Pepcid and Tagamet, which don't contain ranitidine.
Although Sanofi, the company that owns Zantac, hasn't issued a recall, the drug companies Apotex Corp. and Sandoz Inc. announced they're voluntarily recalling all of their ranitidine-based products sold in the U.S. due to the risk.
Potentially Harmful Chemical Detected
About two weeks ago, the FDA reported small amounts of a cancer-causing chemical called N-nitrosodimethylamine (NDMA) were detected in several brand-name and generic heartburn medications.
Even though the FDA identified the carcinogen, the organization isn't yet recommending people stop taking ranitidine products.
This affects the many people who regularly use ranitidine medications to prevent and treat heartburn, ulcers and gastroesophageal reflux disease (GERD).
The FDA is investigating whether the low levels found in the ranitidine medicines create a health risk.
Once the FDA has that information, it'll share it. But for now, the agency isn't recommending people stop taking ranitidine.
"Although NDMA may cause harm in large amounts, the levels the FDA is finding in ranitidine from preliminary tests barely exceed amounts you might expect to find in common foods," Dr. Janet Woodcock, the director of the FDA's Center for Drug Evaluation and Research, said in a statement.
You Don't Need to, but You Can Switch Drugs
Sanofi, the company that makes Zantac, is cooperating with the FDA to ensure the drug is safe for consumers.
"Sanofi takes patient safety seriously and we are committed to working with the FDA. Zantac OTC (over the counter) has been around for over a decade and meets all the specified safety requirements for use in the OTC market," a Sanofi spokesperson told Healthline in an earlier statement.
If you take a medication with ranitidine, you might want to consider opting for a different drug — though it's not necessary at this time.
Cimetidine, known as Tagamet, and famotidine, or Pepcid, are two other types of OTC medications commonly used to treat heartburn and acid reflux.
If you have a prescription, your doctor can recommend another treatment option.
"While Zantac may prove safe in the long run, this latest statement adds confusion and concern so my interim advice to patients is simple: switch to another drug (there are other options), and of course confirm with your doctor the need for an antacid," Dr. David Robbins, the associate chief of endoscopy at Lenox Hill Hospital, said in statement.
Dr. Linda Nguyen, a gastroenterologist at Stanford Health Care in California, has similar advice.
"According to the FDA alert, the issue does not appear to be related to the drug class but due to contaminants specific to ranitidine," Nguyen told Healthline.
"Ranitidine is an H2 (histamine-2) blocker that decreases the acidity in the stomach. It is frequently used for heartburn and dyspepsia (stomach upset or indigestion). Ranitidine is available over the counter and [by] prescription. There are alternative H2 blockers available in the U.S., including famotidine (Pepcid) or cimetidine (Tagamet). Patients should consult with their clinician or pharmacist for equivalent dose conversions," Nguyen said.
What Is NDMA?
NDMA is an environmental contaminant found in water along with meat, dairy and vegetables.
It's classified as a B2 carcinogen, meaning it's a probable human carcinogen. Exposure to high amounts of NDMA is thought to cause gastric or colorectal cancer, according to the World Health OrganizationTrusted Source.
It's extremely toxic to the liver. Even small amounts may be linked to liver damage.
The chemical was once used to make rocket fuel. Today, the chemical is only used for research purposes in the U.S., according to the Environmental Protection Agency.
The chlorination of drinking and wastewater, which treatment plants do to purify our water, can unintentionally create NDMA as well.
NDMA Was Found in Blood Pressure Drugs Earlier This Year
Since last year, the FDA has been investigating NDMA in certain blood pressure and heart failure medicines categorized as angiotensin II receptor blockers.
In July, the agency issued a handful of recalls of blood pressure medications after a concerning amount of NDMA was found in the drugs valsartan, losartan and irbesartan.
The FDA estimated that if 8,000 people took the highest dose of the recalled valsartan daily for four years, there'd be just one additional cancer case from that group of people.
The FDA stressed the importance of continuing to take the medications until a healthcare provider could recommend a replacement.
If you experience any side effects after taking these blood pressure medications or any heartburn medications with ranitidine, report it to the FDA's MedWatch Program.
The Bottom Line
CVS and Walgreens will no longer sell certain ranitidine heartburn medications, including Zantac.
The news comes after the FDA announced that ranitidine heartburn medications may contain traces of a cancer-causing chemical known as N-nitrosodimethylamine (NDMA).
The agency is currently looking into the health risks associated with the amount of NDMA identified in the drugs. It will post more information as it learns more.
As of now, the FDA isn't recommending people stop taking ranitidine, but those who'd like to switch medications should talk to their doctor about other treatment options.
Reposted with permission from our media associate Healthline.
EcoWatch Daily Newsletter
- Beat the COVID-19 Blues With These Wildlife and Nature Livecams ... ›
- Bald Eagles Are Still Dying From Lead Poisoning - EcoWatch ›
- Ospreys' Recovery From Pollution and Shooting Is a Global ... ›
The office may never look the same again. And the investment it will take to protect employees may force many companies to go completely remote. That's after the Centers for Disease Control and Prevention (CDC) issued new recommendations for how workers can return to the office safely.
- Trump Admin Rejects CDC Reopening Guidelines - EcoWatch ›
- Trump Labor Department Encourages States to Report Workers ... ›
- White House Ordered Coronavirus Meetings Be Classified - EcoWatch ›
Scientists and art historians are studying art for signs of climate change and to better understand the ways Western culture's relationship to nature has been altered by it, according to the BBC.
- Climate Change, Inspired By Banksy - EcoWatch ›
- Artists and Activists Rise to Fight Climate Change - EcoWatch ›
By Richard Connor
The University of Southern Denmark on Wednesday announced that its researchers have developed the world's first fully automatic robot capable of carrying out throat swabs for COVID-19.
Before you pour a glass of wine, feel the weight of the bottle in your hand. Would you notice if it were a few ounces lighter? Jackson Family Wines is betting that you won't.
After a minor setback, a new era in space travel and tourism is set to launch this weekend.
When the SpaceX shuttle launches its private spacecraft, the Crew Dragon, with NASA astronauts in tow, it will mark the beginning of commercialized space exploration. SpaceX
NASA astronauts Doug Hurley and Bob Behnken will man the SpaceX Crew Dragon to the International Space Station. NASA
- SpaceX Launches and Lands World's First Recycled Rocket ... ›
- Dear Elon Musk: Your Dazzling Mars Plan Overlooks Some Big ... ›
- Everything you need to know about SpaceX's historic astronaut launch ›
- Crew Dragon Launch Day Timeline: From Suit up to Docking with ... ›
- Updates to Coverage of NASA SpaceX Commercial Crew Test Flight ... ›
- SpaceX's first ever commercial space flight a pit stop on Elon Musk's ... ›
- SpaceX will launch private citizens into orbit - The Verge ›
Former Federal Reserve Governor Rebukes Fed for Using Covid-19 Funds to Bail Out Fossil Fuel Industry
By Eoin Higgins
A former Federal Reserve board of governors member on Thursday called on her former colleagues to stop using Covid-19 relief funds to bail out the "dying" fossil fuel industry, calling the decision a threat to the planet's climate and a misguided use of taxpayer money.
<iframe width="100%" height="150" scrolling="no" class="rm-shortcode twitter-embed-1266004825050939393" id="twitter-embed-1266004825050939393" lazy-loadable="true" src="/res/community/twitter_embed/?iframe_id=twitter-embed-1266004825050939393&created_ts=1590674046.0&screen_name=collinrees&text=The+last+thing+the+Fed+should+be+doing+is+bailing+one+of+world%27s+riskiest+industries+%E2%80%94+fossil+fuels.%0A%0AWe+know+Big+O%E2%80%A6+https%3A%2F%2Ft.co%2Fu4d5SoHy83&id=1266004825050939393&name=Collin+Rees" frameborder="0" data-rm-shortcode-id="a0e370c95211a3c2f9a65eda5a075be6"></iframe>
<iframe width="100%" height="150" scrolling="no" class="rm-shortcode twitter-embed-1266068654724132864" id="twitter-embed-1266068654724132864" lazy-loadable="true" src="/res/community/twitter_embed/?iframe_id=twitter-embed-1266068654724132864&created_ts=1590689264.0&screen_name=Western_Values&text=Oil%2C+gas%2C+and+coal+companies+are+set+to+receive+billions+in+federal+aid+from+both+the+%23PPP+and+%23CARESAct.+Many+of+t%E2%80%A6+https%3A%2F%2Ft.co%2FmX370hwkg1&id=1266068654724132864&name=Western+Values+Project" frameborder="0" data-rm-shortcode-id="c000bc798f2c320613914689edb3c330"></iframe>
- The $88 Billion Fossil Fuel Bailout for Oil, Gas and Coal Exploration ... ›
- Fossil Fuel Firms With Ties to Trump Administration Get Small ... ›
- Big Oil Taking $1.9 Billion in CARES Act Tax Breaks - EcoWatch ›